Objective of the research: to analyze clinical and laboratory manifestations of COVID-19 with apredominant lesion of the gastrointestinal tract (GIT) in children. It was revealed that incidence of this form of COVID-19 in children is underestimated. Based on the analysis of literature data andoriginal clinical observations, the article describes current ideas about the frequency of detecting the form of COVID-19 with a predominant lesion of the GIT, its clinical and laboratory characteristics, the mechanisms of infectious process development in the digestive organs and approaches to rational laboratory diagnostics. The feasibility of PCR in feces in patients with suspected COVID-19 is confirmed. A description of a clinical case of COVID-19 severe form, which required differential diagnosis with acute bacterial gastroenterocolitis, is presented.
1. A.S. Shamsutdinov, U.K Abdullaeva, N.S Akhmedova. Determination of the level of pepsinogens in patients with chronic h. pylori associated gastritis // ACADEMICIA: An international multidisciplinary research journal 11 (2), 919-924 2. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genomestructure, replication, and pathogenesis. Journal of MedicalVirology. 2020; 92 (4): 418–423. 3. Coronavirus replication and reverse genetics. Brian DA,Baric RS, eds. Springer, Berlin, Heidelberg, 2005: 30. 4. G.N. Sobirova, U.K. Abdullaeva. Chronic gastritis and carcinogenesis issues//Central Asian Problems of Modern Science and Education 4 (2), 159-172 5. G.N. Sobirova, U.K. Abdullaeva. Immunopatogenesis of chronic gastritis and its role in carcinogenesis // Biomedicine and practice 1(4) 20-27 6. Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestationsand potential fecal–oral transmission. Gastroenterology.2020; 158 (6): 1518–1519. 7. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Arechildren less susceptible to COVID-19? Journal of Microbiology,Immunology, and Infection. 2020; 53 (3): 371–372. 8. M.M. Karimov, G.N. Sobirova, U.K. Abdullayeva // Chronic gastritis and carcinogenesis issuesHerald of Pancreatic Club 45 (4), 65-70 9. Park M, Cook AR, Lim JT, Sun Y, Dickens BL. ASystematic review of COVID-19 epidemiology based on currentevidence. Journal of Clinical Medicine. 2020; 9 (4): 967. 10. Rawat M, Rawat M, Chandrasekharan P, Hicar MD,Lakshminrusimha S. COVID-19 in Newborns and Infants–LowRisk of Severe Disease: Silver Lining or Dark Cloud? AmericanJournal of Perinatology. 2020; 37 (8): 845–849. 11. Roujian L, Xiang Z, Juan L, Peihua N, Bo Y, Honglong W,et al. Genomic characterisation and epidemiology of 2019novel coronavirus: implications for virus origins and receptorbinding. Lancet. 2020; 395 (10224): 565–574. 12. S.G. Naimovna, A.U. Kurbanovna, N.M. Shukurloevna, A.I. Jabborovna. Evaluation of the gastrointestinal mucosa by the OlgA system in chronic atrophic gastritis // Journal of Critical Reviews 7 (2), 409-413 13. Shaoshuai W, Lili G, Ling C, Weiyong L, Yong C,Jingyi Z, Ling F. A case report of neonatal COVID-19 infectionin China. Clinical Infectious Diseases. 2020. URL: https://covid-19.conacyt.mx/jspui/handle/1000/5575 (дата обращения: 30.07.2020). 14. She J, Liu L, Liu W. COVID-19 epidemic: diseasecharacteristics in children. Journal of Medical Virology. 2020;92: 747–754. 14. Surveillances V. The epidemiological characteristics ofan outbreak of 2019 novel coronavirus diseases (COVID-19) –China, 2020. China CDC Weekly. 2020; 2 (8): 113–122. 15. U.K. Abdullaeva Predicting the risk of atrophic transformation in chronic gastritis using serum pepsinogen // World journal of pharmaceutical research Iss. 8 (13) 219-228 16. U.K. Abdullaeva, A.I. Jabborovna, T.F. Mukhuddinovna, K.M. Mirvasikovich. Serological Diagnostics Of Atrophy Of The Gastric Mucosa // The American Journal of Medical Sciences and Pharmaceutical Research2 (12), 118-124 17. U.K. Abdullaeva, G.N. Sobirova, M.M. Karimov, I.J. Aslonova. The prevalence and possibilities of prevention of noncardial gastric cancer in the Bukhara region // American journal of medicine and medical sciences 10 (9), 679-681 18. U.K. Abdullaeva, N.S. Shadjanova. Using the OLGA system in chronic atrophic gastritis // New day in medicine, 9-12 19. U.K. Abdullaeva, A.I. Jabborovna, T.F. Mukhuddinovna, K.M. Mirvasikovich, S.G. Naimovna. Possibilities of Serological Diagnosis of Atrophic Processes of the Gastric Mucosa // European Journal of Molecular & Clinical Medicine 7 (11), 2955-2960 20. U.K. Abdullaeva, A.I. Jabborovna, T.F. Mukhuddinovna, K.M. Mirvasikovich, S.G. Naimovna. Possibilities of Serological Diagnosis of Atrophic Processes of the Gastric Mucosa // Annals of the Romanian Society for Cell Biology, 6168-6174 21. Van Doremalen N, Bushmaker T, Morris DH, HolbrookMG, Gamble A, Williamson BN, et al. Aerosol and surfacestability of SARS-CoV-2 as compared with SARS-CoV-1. NewEngland Journal of Medicine. 2020; 382 (16): 1564–1567. 22. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injuryduring highly pathogenic human coronavirus infections. LiverInternational. 2020; 40 (5): 998–1004. 23. Zhang C, Shi L, Wang FS. Liver injury in COVID-19:management and challenges. The Lancet Gastroenterology &Hepatology. 2020; 5 (5): 428–430. 24. Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al.Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entryprocess. Gut. 2020; 69 (6): 1010–1018. 25. Zhu N, Zhang D, Wang W, Wang W, Li X, Yang B,et al. A novel coronavirus from patients with pneumonia inChina, 2019. New England Journal of Medicine. 2020; 382:727–733.
Ismatova, Mekhriniso N. and Shadjanova, Nigora S.
"GASTROINTESTINAL TRACT LESION WITH A COVID-19,"
Central Asian Journal of Medicine: Vol. 2021
, Article 5.
Available at: https://uzjournals.edu.uz/tma/vol2021/iss3/5